Brief: Datametrex AI Says Seasun Biomaterial's COVID-19 Tests Kits Received U.S. FDA Authorization
09/06/2020 12:45
June 9 (Reuters) - Datametrex AI Ltd DM.V :
* DATAMETREX AI - SEASUN BIOMATERIAL'S 20 MINUTE RAPID
NUCLEIC
ACID TEST KIT, AQ-TOP COVID-19 RAPID DETECTION KIT, HAS RECEIVED
AUTHORIZATION FROM U.S. FDA
Source text for Eikon: ID:nGNX7PzQs2
Further company coverage: DM.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Quanta AI
See all newsBrief: Datametrex Receives Largest Covid-19 Test Kits Order To Date For $1.6M From A Canadian Mining Company
Brief: Datametrex Applies To Health Canada For 5 Minute Fast Antigen Kit
Brief: Datametrex AI Appoints Don Shim As CFO
Brief: Datametrex Secures COVID-19 Antigen Detection Kits
Brief: Datametrex Announces Shares For Debt Settlement